Format

Send to

Choose Destination
See comment in PubMed Commons below
Respir Res. 2001;2(3):150-6. Epub 2001 Mar 29.

Eotaxin and the attraction of eosinophils to the asthmatic lung.

Author information

  • 1Leukocyte Biology Section, Biomedical Sciences Division, Imperial College School of Medicine, London, UK. d.conroy@ic.ac.uk

Abstract

Eosinophilic leukocytes accumulate in high numbers in the lungs of asthmatic patients, and are believed to be important in the pathogenesis of asthma. A potent eosinophil chemoattractant is produced in the asthmatic lung. This small protein, the chemokine eotaxin, is synthesized by a number of different cell types, and is stimulated by interleukin-4 and interleukin-13, which are produced by T-helper (Th)2 lymphocytes. Low molecular weight compounds have been developed that can block the eotaxin receptor C-C chemokine receptor (CCR)3, and prevent stimulation by eotaxin. This provides the potential for orally available drugs that can prevent eosinophil recruitment into the lung and the associated damage and dysfunction.

PMID:
11686879
PMCID:
PMC2002069
[PubMed - indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for PubMed Central
    Loading ...
    Support Center